Trials Sponsors Conditions Drugs Pricing

Conditions

Difficulty in Sleep Initiation

Outcome Measures

Primary Outcomes (2)

Change in quality of sleep
To evaluate the effectiveness of test treatment in terms of change in quality of sleep by using Leed Sleep evaluation Questionnarie in which 0 indicate more difficult to 10 indicate Easier than usual
From Baseline Day 01 (before usage) and Day 15 (post usage)
Change in duration sleep
To evaluate the effectiveness of test treatment in terms of change in duration of sleep by using Leed Sleep evaluation Questionnarie in which 0 indicate more difficult to 10 indicate easier than usual
From Baseline Day 01 (before usage) and Day 15 (post usage)

Secondary Outcomes (10)

Change in sleep quality by subjective self evaluated
From Day -7 (before usage) and Day 15 (post usage)
Improvement in overall health and wellbeing
From Baseline Day 01 (before usage) and Day 15 (post usage)
Subject product perception questionnaire
Day 15 (post usage)
Subject treatment perception
Day 30 (post usage)
Change in Complete Blood Count
From Baseline Day 01 (before usage) and Day 15 (post usage)
+5 more secondary outcomes

Study Arms (1)

Zzowin Nutra Tablet

EXPERIMENTAL

Zzowin Nutra Tablet contains Melatonin, Tagar, L-theanine, L-Tryptophan, vitamin B6, Iron, Zinc, and Magnesium. which is helpful to provide deep, calm, and restful sleep.

Drug: Zzowin Nutra Tablet

Interventions

Zzowin Nutra TabletDrug

1 Tablet daily half an hour before going to bed

Also known as: Herbal Supplement

Zzowin Nutra Tablet

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 65 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Age: 18 to 65 years (both inclusive) at the time of consent.
Sex: Healthy non-pregnant/non-lactating females and males.

Sponsors & Collaborators

Vedistry Private Limited
Type not reportedcollaborator
NovoBliss Research Pvt Ltd
Otherlead

Study Sites (1)

NovoBliss Research Pvt Ltd

Gandhinagar, Gujarat, 382421, India

MeSH Terms

Interventions

Dietary Supplements

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

Dr. Nayan K Patel, MBBS
Medical Director
PRINCIPAL INVESTIGATOR

Enrollment

32 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: SUPPORTIVE CARE
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal Investigator-Medical Director

Study Record Dates

First Submitted

April 5, 2023

First Posted

May 11, 2023

Study Start

April 17, 2023

Actual (reported)

A Clinical Study to Assess the Safety and Effectiveness of Herbal Supplement in Adult Human Subjects.

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (10)

Study Arms (1)

Zzowin Nutra Tablet

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (10)

Study Arms (1)

Zzowin Nutra Tablet

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations